Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma

References

1. 1.↵
   1. Lee AW,
   2. Ng WT,
   3. Chan LL, et al

   . Evolution of treatment for nasopharyngeal cancer: success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 2014;110:377–84 doi:10.1016/j.radonc.2014.02.003 pmid:24630534

   CrossRefPubMed
2. 2.↵
   1. Chan KC,
   2. Woo JK,
   3. King A, et al

   . Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med 2017;377:513–22 doi:10.1056/NEJMoa1701717 pmid:28792880

   CrossRefPubMed
3. 3.↵
   1. King AD,
   2. Vlantis AC,
   3. Bhatia KS, et al

   . Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy. Radiology 2011;258:531–37 doi:10.1148/radiol.10101241 pmid:21131580

   CrossRefPubMed
4. 4.↵
   1. King AD,
   2. Woo JK,
   3. Ai QY, et al

   . Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. Ann Oncol 2019;30:977–82 doi:10.1093/annonc/mdz106 pmid:30912815

   CrossRefPubMed
5. 5.↵
   1. Shayah A,
   2. Wickstone L,
   3. Kershaw E, et al

   . The role of cross-sectional imaging in suspected nasopharyngeal carcinoma. Ann R Coll Surg Engl 2019;101:325–27 doi:10.1308/rcsann.2019.0025 pmid:30855169

   CrossRefPubMed
6. 6.↵
   1. King AD,
   2. Vlantis AC,
   3. Yuen TW, et al

   . Detection of nasopharyngeal carcinoma by MR imaging: diagnostic accuracy of MRI compared with endoscopy and endoscopic biopsy based on long-term follow-up. AJNR Am J Neuroradiol 2015;36:2380–85 doi:10.3174/ajnr.A4456 pmid:26316564

   Abstract/FREE Full Text
7. 7.↵
   1. King AD,
   2. Vlantis AC,
   3. Tsang RK, et al

   . Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2006;27:1288–91 doi:10.3174/ajnr.A5493 pmid:16775281

   Abstract/FREE Full Text
8. 8.↵
   1. King AD,
   2. Wong LY,
   3. Law BK, et al

   . MR imaging criteria for the detection of nasopharyngeal carcinoma: discrimination of early-stage primary tumors from benign hyperplasia. AJNR Am J Neuroradiol 2018;39:515–23 doi:10.3174/ajnr.A5493 pmid:29284600

   Abstract/FREE Full Text
9. 9.↵
   1. Wang ML,
   2. Wei XE,
   3. Yu MM, et al

   . Value of contrast-enhanced MRI in the differentiation between nasopharyngeal lymphoid hyperplasia and T1 stage nasopharyngeal carcinoma. Radiol Med 2017;122:743–51 doi:10.1007/s11547-017-0785-z pmid:28647899

   CrossRefPubMed
10. 10.↵
    1. Li K,
    2. Lin GZ,
    3. Shen JC, et al

    . Time trends of nasopharyngeal carcinoma in urban Guangzhou over a 12-year period (2000–2011): declines in both incidence and mortality. Asian Pac J Cancer Prev 2014;15:9899–903 doi:10.7314/apjcp.2014.15.22.9899 pmid:25520125

    CrossRefPubMed
11. 11.↵
    1. Amin MB,
    2. Edge SB,
    3. Greene FL

    , et al., eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer-Verlag; 2017
12. 12.↵
    1. van den Brekel MW,
    2. Stel HV,
    3. Castelijns JA, et al

    . Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379–84 doi:10.1148/radiology.177.2.2217772 pmid:2217772

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Zhang G,
    2. Liu L,
    3. Wei W, et al

    . Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology 2010;255:605–12 doi:10.1148/radiol.10090289 pmid:20413770

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Hawass N

    . Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 1997;70:360–66 doi:10.1259/bjr.70.832.9166071 pmid:9166071

    Abstract
15. 15.↵
    1. Kundel HL,
    2. Polansky M

    . Measurement of observer agreement. Radiology 2003;228:303–08 doi:10.1148/radiol.2282011860 pmid:12819342

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Guo R,
    2. Tang LL,
    3. Mao YP, et al

    . Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer 2019;125:79–89 doi:10.1002/cncr.31741 pmid:30351466

    CrossRefPubMed
17. 17.↵
    1. King AD,
    2. Ahuja AT,
    3. Leung SF, et al

    . Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000;22:275–81 doi:10.1002/(sici)1097-0347(200005)22:3<275::aid-hed10>3.0.co;2-n pmid:10748451

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Ai QY,
    2. King AD,
    3. Chan JS, et al

    . Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI. Eur Radiol 2019;29:5627–34 doi:10.1007/s00330-019-06133-8 pmid:30903340

    CrossRefPubMed
19. 19.↵
    1. Lam WK,
    2. Jiang P,
    3. Chan KCA, et al

    . Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 2018;115:E5115–24 doi:10.1073/pnas.1804184115 pmid:29760067

    Abstract/FREE Full Text